Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients

Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Axelrod, David A., Lentine, Krista L., Balakrishnan, Ramji, Chang, Su-Hsin, Alhamad, Terek, Xiao, Huiling, Kasiske, Bertran L., Bloom, Roy D., Schnitzler, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Kidney Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/
https://ncbi.nlm.nih.gov/pubmed/33204825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados